MTX110
MTX110-102
Phase 1 small_molecule terminated
Quick answer
MTX110 for Recurrent Glioblastoma is a Phase 1 program (small_molecule) at Biodexa Pharmaceuticals Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biodexa Pharmaceuticals Plc
- Indication
- Recurrent Glioblastoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated